Cargando…
Acid ceramidase confers radioresistance to glioblastoma cells
Glioblastoma multiforme (GBM) is the most common primary, intracranial malignancy of the central nervous system. The standard treatment protocol, which involves surgical resection, and concurrent radiation with adjuvant temozolomide (TMZ), still imparts a grim prognosis. Ultimately, all GBMs exhibit...
Autores principales: | Doan, Ninh B., Nguyen, Ha S., Al-Gizawiy, Mona M., Mueller, Wade M., Sabbadini, Roger A., Rand, Scott D., Connelly, Jennifer M., Chitambar, Christopher R., Schmainda, Kathleen M., Mirza, Shama P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652937/ https://www.ncbi.nlm.nih.gov/pubmed/28765947 http://dx.doi.org/10.3892/or.2017.5855 |
Ejemplares similares
-
Acid ceramidase is a novel drug target for pediatric brain tumors
por: Doan, Ninh B., et al.
Publicado: (2017) -
Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency
por: Doan, Ninh B., et al.
Publicado: (2017) -
Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model
por: Doan, Ninh B., et al.
Publicado: (2018) -
Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes
por: Alhajala, Hisham S., et al.
Publicado: (2018) -
TIPS-03 A PHASE 1 STUDY OF GALLIUM MALTOLATE (GAM) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
por: Connelly, Jennifer, et al.
Publicado: (2023)